Related Experiment Video
Updated: May 4, 2026
An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Factors affecting voriconazole plasma concentrations in patients with invasive fungal infections
Objective:
This study retrospectively analyzed the medical records of patients with invasive fungal infections treated with voriconazole in a teaching hospital in order to identify the factors affecting plasma concentrations of voriconazole.
Methods:
Patients treated with voriconazole for invasive fungal infection at the oncology department of the Samsung Medical Center, which is a tertiary teaching hospital located in Seoul, Korea, between January 2010 and May 2012 were statistically analyzed for the identification of factors affecting plasma concentrations of voriconazole.
Results:
Of the 64 patients analyzed, 3 patients who were also treated with cytochrome P450 (CYP) 2C19 inducers showed a statistically lower plasma concentration of voriconazole compared to the other 61 patients (p = 0.034). Factors such as sex, underlying disease, age, and voriconazole dosage were not significantly associated with the median plasma concentrations of voriconazole. The different administration routes of voriconazole were also not significantly associated with the median plasma concentration, but there was a tendency for higher plasma concentrations in 28 patients receiving the drug intravenously compared to 36 patients who received it orally.
Conclusions:
We found that patients with invasive fungal infections receiving voriconazole and CYP2C19 inducers concomitantly had significantly lower plasma concentrations of voriconazole compared to the other patients. In addition, there was a tendency for patients to have a higher plasma concentration of voriconazole when it was administered intravenously. However, additional prospective studies are needed to confirm these results and apply them to routine clinical practice. In the future it will be important to monitor plasma concentrations of voriconazole while considering the influence of various factors that could affect the concentrations.
Related Concept Videos
01:19Factors Affecting Drug Distribution: Miscellaneous Factors
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
01:19Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...